After the launch of the ANMOL scheme to provide screening tests for genetic and metabolic disorders in newborns, medical ...
WASHINGTON (7News) — Reporter's Notebook: Every year, thousands of infants in America are diagnosed with devastating genetic diseases through newborn screenings. The encouraging news is that many of ...
Preterm babies face greater health risks from the moment they are born. Their organs, immune systems, and metabolic pathways are not fully developed, making them more vulnerable to complications.
Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions. The drug fosdenopterin/rcPMP ...
Genetic newborn screening supports early identification of a child’s critical condition, guiding to a better start in life. Large-scale evidence shows that adding next-generation sequencing (NGS) as a ...